Nakasone Y - Search Results

1

[Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Head and neck cancer].

Nakasone Y, Mogi K, Endo K. Nakasone Y, et al. Nihon Igaku Hoshasen Gakkai Zasshi. 2002 May;62(6):258-64. Nihon Igaku Hoshasen Gakkai Zasshi. 2002. PMID: 12073631 Review. Japanese.

2

Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.

Tian M, Zhang H, Nakasone Y, Mogi K, Endo K. Tian M, et al. Among authors: nakasone y. Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):5-12. doi: 10.1007/s00259-003-1316-9. Epub 2003 Oct 10. Eur J Nucl Med Mol Imaging. 2004. PMID: 14551748 Clinical Trial.

3

Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET.

Miyakubo M, Oriuchi N, Tsushima Y, Higuchi T, Koyama K, Arai K, Paudyal B, Iida Y, Hanaoka H, Ishikita T, Nakasone Y, Negishi A, Mogi K, Endo K. Miyakubo M, et al. Among authors: nakasone y. Ann Nucl Med. 2007 Feb;21(2):129-35. doi: 10.1007/BF03033991. Ann Nucl Med. 2007. PMID: 17424980

4

Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy.

Ishikita T, Oriuchi N, Higuchi T, Miyashita G, Arisaka Y, Paudyal B, Paudyal P, Hanaoka H, Miyakubo M, Nakasone Y, Negishi A, Yokoo S, Endo K. Ishikita T, et al. Among authors: nakasone y. Ann Nucl Med. 2010 Feb;24(2):77-82. doi: 10.1007/s12149-009-0326-5. Ann Nucl Med. 2010. PMID: 20058105 Clinical Trial.

5

The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.

Nakasone Y, Inoue T, Oriuchi N, Takeuchi K, Negishi A, Endo K, Mogi K. Nakasone Y, et al. Ann Nucl Med. 2001 Dec;15(6):505-12. doi: 10.1007/BF02988503. Ann Nucl Med. 2001. PMID: 11831398

6

Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging.

Tian M, Zhang H, Higuchi T, Oriuchi N, Nakasone Y, Takata K, Nakajima N, Mogi K, Endo K. Tian M, et al. Among authors: nakasone y. Ann Nucl Med. 2005 Jun;19(4):335-8. doi: 10.1007/BF02984629. Ann Nucl Med. 2005. PMID: 16097646 Clinical Trial.

7

¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry.

Miyashita G, Higuchi T, Oriuchi N, Arisaka Y, Hanaoka H, Tominaga H, Morita S, Miyakubo M, Ishikita T, Nakasone Y, Negishi A, Yokoo S, Endo K. Miyashita G, et al. Among authors: nakasone y. Ann Nucl Med. 2010 Oct;24(8):579-84. doi: 10.1007/s12149-010-0398-2. Epub 2010 Jul 21. Ann Nucl Med. 2010. PMID: 20652456 Clinical Trial.

8

The resection of non-hepatic intraabdominal recurrence of gastric cancer.

Takeyoshi I, Ohwada S, Ogawa T, Kawashima Y, Ohya T, Kawate S, Nakasone Y, Arai K, Ikeya T, Morishita Y. Takeyoshi I, et al. Among authors: nakasone y. Hepatogastroenterology. 2000 Sep-Oct;47(35):1479-81. Hepatogastroenterology. 2000. PMID: 11100381

9

Esophageal anastomosis following gastrectomy for gastric cancer: comparison of hand-sewn and stapling technique.

Takeyoshi I, Ohwada S, Ogawa T, Kawashima Y, Ohya T, Kawate S, Arai K, Nakasone Y, Morishita Y. Takeyoshi I, et al. Among authors: nakasone y. Hepatogastroenterology. 2000 Jul-Aug;47(34):1026-9. Hepatogastroenterology. 2000. PMID: 11020870

10

Blood transfusions impair anastomotic wound healing, reduce luminol-dependent chemiluminescence, and increase interleukin-8.

Okano T, Ohwada S, Sato Y, Sato N, Toyama Y, Nakasone Y, Ogawa T, Morishita Y. Okano T, et al. Among authors: nakasone y. Hepatogastroenterology. 2001 Nov-Dec;48(42):1669-74. Hepatogastroenterology. 2001. PMID: 11813598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters